Actively Recruiting
Effect of Transcutaneous Acupoint Electrical Stimulation on Postoperative Cough in Lung Cancer Patients Randomized, Double-Blind, Controlled Clinical Trial
Led by Kong Fanming · Updated on 2025-09-08
84
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the effects of Transcutaneous Acupoint Electrical Stimulation (TAES) on improving cough symptoms in patients who have undergone lung cancer surgery. This trial aims to evaluate changes in cough severity using various measures, including the Cough Symptom Score (CSS), Visual Analog Scale (VAS), and the Leicester Cough Questionnaire-Mandarin Chinese version (LCQ-MC). The study also seeks to assess patients' overall evaluation of the treatment and identify those who may benefit most from TAES as a non-drug therapy for postoperative cough. Participants are randomly assigned to one of two groups: the TEAS group receiving actual electrical stimulation at specific acupuncture points, and the sham TEAS group receiving electrode placement without active stimulation. The treatment involves applying electrode patches to cleaned skin while the patient is seated, with electrical pulses delivered at a frequency of 2 Hz in the active group. The study includes treatment and follow-up periods, with assessments conducted before treatment, at the end of treatment (week 2), and two weeks post-treatment (week 4). Throughout the study, participants complete clinical observation forms and undergo evaluations including the LCQ-MC to measure cough-related quality of life. Clinical data are collected and analyzed to report results. Patients are monitored for treatment adherence and any adverse effects. The total participation lasts for at least four weeks, covering baseline, treatment, and follow-up assessments to observe changes in cough symptoms and overall treatment impact.
CONDITIONS
Brief Title
Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years old
- Surgery performed under general anesthesia for radical lung cancer resection or lung cancer resection with lymph node dissection
- Pathological confirmation of primary lung cancer after surgery
- Persistent dry cough lasting 2 weeks or more after lung surgery
- Consciousness with ability to express opinions clearly and voluntary informed consent signed
You will not qualify if you...
- Acute respiratory system diseases diagnosed within 1 month
- Pneumonia diagnosed by chest X-ray
- History of asthma or tuberculosis
- Uncontrolled hyperthyroidism, severe hypertension, heart disease, systemic infection, coagulation disorders, or other severe systemic diseases
- Use of steroid drugs within past 3 months
- Use of angiotensin-converting enzyme inhibitors within past 6 months
- Surgical incisions, skin allergies, wounds, or infections in the treatment area
- Inability to tolerate or withdrawal from transcutaneous acupoint electrical stimulation
- Contraindications to electrical stimulation or implanted electrophysiological devices
- Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 weeks
Participants receive transcutaneous acupoint electrical stimulation (TAES) or sham treatment to evaluate its effect on postoperative cough in lung cancer patients.
Regular treatment sessions during the 2-week period
Duration - 2 weeks
Participants are monitored for changes in cough symptoms 2 weeks after the end of treatment.
1 follow-up visit
Trial Site Locations
Total: 1 location
1
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China, 300193
Actively Recruiting
Research Team
F
Fanming Kong, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here